Host-Derived Molecules as Novel Chagas Disease Biomarkers: Hypercoagulability Markers and Extracellular Vesicles

dc.contributor.authorBerta Barnadas-Carceller
dc.contributor.authorDolors Tàssies
dc.contributor.authorIrene Losada
dc.contributor.authorJulio Alonso-Padilla
dc.contributor.authorJoan Carles Reverter
dc.contributor.authorCarmen Fernández-Becerra
dc.contributor.authorMaría‐Jesús Pinazo
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T20:40:13Z
dc.date.available2026-03-22T20:40:13Z
dc.date.issued2025
dc.identifier.doi10.1007/978-1-0716-4848-3_19
dc.identifier.urihttps://doi.org/10.1007/978-1-0716-4848-3_19
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/83375
dc.language.isoen
dc.publisherSpringer Science+Business Media
dc.relation.ispartofMethods in molecular biology
dc.sourceBarcelona Institute for Global Health
dc.subjectExtracellular vesicles
dc.subjectChagas disease
dc.subjectDisease
dc.subjectSerology
dc.subjectMicrovesicles
dc.subjectImmunology
dc.subjectMedicine
dc.subjectBiology
dc.subjectAntibody
dc.subjectBiomarker
dc.titleHost-Derived Molecules as Novel Chagas Disease Biomarkers: Hypercoagulability Markers and Extracellular Vesicles
dc.typebook-chapter

Files